NextCure
NXTC
NXTC
31 hedge funds and large institutions have $5.65M invested in NextCure in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-7
Holders Change %
-18.42%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
10
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
P
1
Pfizer
New York
|
$870K |
| 2 |
O
2
OrbiMed
New York
|
$0 |
| 3 |
TCM
3
Tang Capital Management
San Diego,
California
|
$0 |
| 4 |
4
Citigroup
New York
|
$472K |
| 5 |
5
Federated Hermes
Pittsburgh,
Pennsylvania
|
$0 |
